Metabolic effects of ketohexokinase inhibition in individuals with non-alcoholic fatty liver disease
Latest Information Update: 25 Nov 2024
At a glance
- Drugs PF 06835919 (Primary)
- Indications Non-alcoholic fatty liver disease
- Focus Pharmacodynamics
- Acronyms KHKi in NAFLD
Most Recent Events
- 18 Jan 2024 Status changed from recruiting to completed.
- 26 Aug 2022 Planned initiation date changed from 1 Jul 2022 to 1 Oct 2022.
- 28 Jun 2022 New trial record